NEW YORK, May 30 – RheoGene, a privately held gene expression company based in Charlottesville, Va., announced Wednesday that it had appointed several genomics industry heavyweights to its scientific advisory board.

Michael Ashburner, the joint head of the European Molecular Biology Laboratory and the European Bioinformatics Institute, and Leroy Hood, director of the Institute for Systems Biology, were both named to the board as was Jeffrey Trent, scientific director of the National Human Genome Research Institute.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.